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Objective: Critically ill patients often develop intensive care unit–acquired weakness. Reduction in muscle
mass and muscle strength occurs early after admission to the intensive care unit (ICU). Although early active
muscle training could attenuate this intensive care unit–acquired weakness, in the early phase of critical
illness, a large proportion of patients are unable to participate in any active mobilization. Neuromuscular
electrical stimulation (NMES) could be an alternative strategy formuscle training. The aim of this studywas to
investigate the safety and feasibility of NMES in critically ill patients.
Design: This is an observational study.
Setting: The setting is in the medical and surgical ICUs of a tertiary referral university hospital.
Patients: Fifty patientswith a prognosticated prolonged stay of at least 6 dayswere included on day 3 to 5 of their
ICU stay. Patients with preexisting neuromuscular disorders and patients with musculoskeletal conditions
limiting quadriceps contraction were excluded.
Intervention: Twenty-five minutes of simultaneous bilateral NMES of the quadriceps femoris muscle.
This intervention was performed 5 days per week (Monday-Friday). Effective muscle stimulation was defined
as a palpable and visible contraction (partial or full muscle bulk).
Measurements: The following parameters, potentially affecting contraction upon NMES, were assessed:
functional status before admission to the ICU (Barthel index), type and severity of illness (Acute Physiology
And Chronic Health Evaluation II score and sepsis), treatments possibly influencing the muscle contraction
(corticosteroids, vasopressors, inotropes, aminoglycosides, and neuromuscular blocking agents), level of
consciousness (Glasgow Coma Scale, score on 5 standardized questions evaluating awakening, and sedation
agitation scale), characteristics of stimulation (intensity of the NMES, number of sessions per patient, and
edema), and neuromuscular electrophysiologic characteristics. Changes in heart rate, blood pressure, oxygen
saturation, respiratory rate, and skin reactions were registered to assess the safety of the technique.
Results: In 50% of the patients, an adequate quadriceps contraction was obtained in at least 75% of the NMES
sessions. Univariate analysis showed that lower limb edema (P b .001), sepsis (P = .008), admission to the
medical ICU (P= .041), and treatment with vasopressors (P= .011) were associated with impaired quadriceps
contraction. A backward multivariate analysis identified presence of sepsis, lower limb edema, and use of
vasopressors as independent predictors of impaired quadriceps contraction (R2 = 59.5%). Patients responded
better to NMES in the beginning of their ICU stay in comparison with after 1 week of ICU stay. There was no
change in any of the safety end points with NMES.
Conclusions: Critically ill patients having sepsis, edema, or receiving vasopressors were less likely to respond to
NMESwith an adequate quadriceps contraction. Neuromuscular electrical stimulation is a safe intervention to be
administered in the ICU.
© 2014 Elsevier Inc. All rights reserved.ave no conflicts of interest.
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ibilityof neuromuscular electr1. Introduction
Outcome and survival rate of critically ill patients has improved
over the last decades by new approaches of mechanical ventilation
and advancements in critical care [1,2]. Nevertheless, the associated
respiratory and multiorgan failure often necessitates a long intensiveical stimulation in critically ill patients, J Crit Care (2014), http://dx.doi.
2 J. Segers et al. / Journal of Critical Care xxx (2014) xxx–xxxcare unit (ICU) stay, where invasive therapeutic modalities such as
mechanical ventilation, circulatory support, and the use of sedative
agents, neuromuscular blockers, corticosteroids or certain antibiotics
will negatively affect muscle mass and force [3]. On top of that,
these patients have reduced physical activity and are immobilized
in their bed, which will further increase muscle catabolism and
decrease muscle protein synthesis and muscle mass [4]. This muscle
dysfunction is often referred to as intensive care unit–acquired
weakness (ICU-AW) [4]. Intensive care unit–acquired weakness is
associated with prolonged mechanical ventilation and increased
mortality [5]. The consequences of ICU-AW may persist even years
after ICU discharge, leading to impaired functional status and decrease
in quality of life [3,6].
Muscle wasting starts early and fast, and the largest loss of
mass and function occurs during the first 2 weeks of ICU stay [7],
with a decrease of 17.7% in the first 10 days [8]. Therefore, it is
important to prevent or attenuate this muscle deconditioning as
early as possible in patients with expected prolonged bed rest.
It has been demonstrated that early exercise training in critically
ill patients receiving mechanical ventilation is feasible, safe, and
beneficial for respiratory and limb muscles [9,10]. However,
severely critically ill patients, often under the influence of sedative
drugs, cannot collaborate in active exercise or muscle training.
Neuromuscular electrical stimulation (NMES) is a treatment
modality to evoke a muscle contraction through an electrical
impulse via surface electrodes. For this technique, no patient
cooperation is required. Recently, the application of NMES on the
ICU has gained interest [11-15]. The effectiveness of NMES was
studied during the “acute phase” of critical illness in several
studies with very limited patient numbers. Some of these studies
suggest beneficial effects on cross-sectional diameter loss of the
quadriceps and decreased development of critical illness poly-
neuromyopathy [11,16]. Other studies, however, were unable to
revert muscle wasting in the acute phase [12,13]. A review on
NMES in acutely ill patients confirms this [17] but states that
NMES is capable of preventing ICU-AW. Another review, however
[18], shows that this evidence is not conclusive. The ability to elicit
muscle contraction with NMES might be hampered due to
myopathy [13,19], peripheral edema [20], sepsis [13], or medica-
tion [21]. All these factors were not considered in the previous
studies on NMES in critically ill patients and might be important
in the selection of patients and consequently the effectiveness of
the intervention.
Rodriguez et al [14] reported that adequate muscle contractions
(at least just palpable and visible) were observed in 77% of the
sessions. However, differences between patients with a successful
contraction and patients without contraction were not reported, and
no explanation was given for this difference. Furthermore, ICU
patients with edema were excluded from NMES in previous studies
[12,15]. However, the ability to elicit a muscle contraction was
never studied in ICU patients with edema [21]. In addition,
questions may rise about the safety of NMES when an electrical
current is applied to the critically ill patient. Only 2 studies reported
heart rate, blood pressure, respiratory rate, and saturation during
NMES [15,22]. Meesen et al [15] observed no changes in these
parameters, whereas Gerovasili et al [22] found a small but
statistically significant raise in heart rate and systolic blood
pressure during NMES. However, the low number of patients in
these studies does not allow final conclusions.
Therefore, this study was designed to investigate the feasibility
and safety of NMES of the quadriceps femoris (QF) muscle in acute
critically ill patients. The aims of the study were to assess the
quality of the muscle contraction, to identify factors potentially
interfering with the quality of the contraction, and to monitor the
safety, that is, the effect of NMES on the cardiorespiratory function
and the skin.Please cite this article as: Segers J, et al, Feasibilityof neuromuscular electr
org/10.1016/j.jcrc.2014.06.0242. Materials and methods
2.1. Study design
This is a prospective cohort study to investigate the feasibility of
NMES in eliciting a muscle contraction of the QF in critically ill
patients. The study was conducted at the University Hospitals Leuven,
Belgium, between November 2010 and November 2012. The medical
ethical committee of the hospital approved the study. Written
informed consent was obtained from all patients or a close relative
in case of sedated or uncooperative patients.
2.2. Patients
On day 3 to 5 after admission to surgical and medical ICU, adult
patients (≥18 years) with an expected prolonged stay of at least 3
more days at the ICU were enrolled in the study. An intensivist
unrelated to the study judged whether the patient was expected to
stay in the ICU for at least 3 more days. When a patient was not
eligible on day 3 due to temporary exclusion criteria, daily
reevaluation was performed and inclusion considered until the
5th day of admission to the ICU. If the patient did not receive an
electrical stimulation session on day 3, 4, or 5, the patient could not be
included anymore.
Exclusion criteria were readmission to the ICU, prognosticated
lethal outcome, presence of a pacemaker, pregnancy, preexisting
neurologic or neuromuscular disease (eg, Duchenne disease, myas-
thenia gravis, and spinal cord lesion), intracranial pressure more than
20 cm H2O, abnormal musculoskeletal, and skin conditions that could
interfere with the stimulation (eg, femur fracture, burn wound on the
thigh, and skin disease). Additional reasons for not starting the NMES
were hemodynamic instability (mean arterial pressure b60 mm Hg),
high fever (N39°), inspired O2 fraction at least 60%, administration of
neuromuscular blocking agents (NMBAs) in the last 24 hours, and
severe agitation in a way that it was impossible to distinguish a
painless NMES contraction from movement by the patient or pain by
the NMES. These reasons for not starting the NMES session were in
accordance with the UZ Leuven Start to Move ASAP guidelines at the
start of the study.
2.3. Intervention
Patients underwent a transcutaneous NMES session during 5 days
per week, from Monday to Friday. All patients received the highest
standard conventional medical treatment and physical therapy during
their stay at the ICU. The physical therapy program consisted of body
positioning, chest physical therapy, active or passive upper and lower
limb mobilization, and cycling in bed or in a chair adjusted to the
individual needs of the patient. The intensity of the treatment was
adjusted according to the clinical condition of the patient using the
“Start-to-Move ASAP UZ Leuven protocol” guidelines [23].
Patients received simultaneous bilateral NMES (device, DUO 500;
Gymna, Bilzen, Belgium) of the QF muscles, 5 days a week for 25
minutes per day until the day of discharge from the ICU. The maximal
output of the device was limited at 80 mA. The patient was positioned
in supine position with the head end of the bed 30° elevated. The legs
were positioned in a neutral position, and a solid knee support roll
was placed under the knees to achieve approximately 15° hip flexion
and 30° knee flexion. Two self-adhesive surface electrodes (oval, 5 ×
10 cm) were placed on the skin overlying the quadriceps muscle as
depicted in Fig. 1.
To quantify the muscle contraction, a grading of the quality
of contraction was designed (see First Online Supplement).
The NMES session started with 5 minutes of warming up with an
intensity to obtain a just palpable and visible contraction (type 3 in
the First Online Supplement).ical stimulation in critically ill patients, J Crit Care (2014), http://dx.doi.
Fig. 1. Placing of electrodes.
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alternating current; frequency, 50 Hz; intensity, 0-80 mA; pulse
duration, 300-500 microseconds; series time, 8 seconds; series pause,
20 seconds; rise time, 2 seconds) was started. Now, a type 4 or 5
contraction (see First Online Supplement) was aimed to be achieved.
When the patient tolerated the stimulation well and no good, visible,
or palpable (type 4) contraction at the intensity of 60 mA was
obtained, the pulse duration was increased to 400 microseconds.
When this was still not sufficient to generate a type 4 contraction, the
intensity was increased to 70 mA. The final steps to achieve a type 4
contractionwere to increase the pulse duration to themaximum of 500
microseconds and to increase the intensity to the maximum of 80 mA.
The intensity and/or pulse duration were adjusted 3 times: in the
beginning, after 5 minutes (of warming-up), and after 15 minutes.
Stimulation intensity and type of contraction (see First Online
Supplement) were noted after 2.5, 10, and 20 minutes.
For all patients, the stimulation intensity was kept below the pain
threshold. In fully sedated patients, we did not have sensory feedback
to adjust the intensity accordingly. In the less sedated patients, facial
expression was important to judge the increase in intensity. Awake
patients were able to guide the intensity of the stimulation.
2.4. Measurements
2.4.1. Feasibility
During the first session, the characteristics of the patient were
recorded: medical diagnosis, age, sex, weight, length, body mass index,
the Acute Physiology And Chronic Health Evaluation (APACHE) II score,
and the Barthel index for preadmission functional independence.
Each NMES session was initiated with an observation of the
patient’s level of consciousness using the Glasgow Coma Scale (GCS),
Score of 5 Questions (S5Q) (5 simple commands to check whether thePlease cite this article as: Segers J, et al, Feasibilityof neuromuscular electr
org/10.1016/j.jcrc.2014.06.024patient was cooperative. For every correct response, the patients
received 1 point. The questions were (1) open/close your eyes,
(2) look at me, (3) open your mouth and put out your tongue, (4) nod
your head and (5) raise your eyebrows when I have counted up to
5) [24], and the Sedation Agitation Scale (SAS) [25]. The level of
edema of the lower limbswasmeasured using the classification added
in the Second Online Supplement. This was performed by the person
administering the electrical stimulation, just before the start of the
NMES session by pressing the index finger on the middle of the
quadriceps muscle and see how long it took for the skin to come back
to its normal form. To define sepsis, the Bone criteria were applied
[26]. Use of the following medication was recorded: corticosteroids,
vasopressors, inotropes, aminoglycosides, and NMBAs.
To detect whether patients responded better to NMES in the
beginning of their ICU period, a comparison of the type of contraction
between session 1 and session 5 was performed. Furthermore, a
correlation analysis between the degree of edema and the type of
contraction was performed for its clinical importance.
In a subgroup of patients (n= 26), nerve conduction studies (NCS)
and electromyography (EMG) were performed on the day of inclusion
and every 7 days from then on as long as the patient stayed on the ICU
by electrophysiologists not related to the ICU. The NCS/EMG did not
take place during the NMES session. The results of the NCS and/or
EMG might contribute to the prediction of successfully eliciting a
contraction. The compound muscle action potential (CMAP), sensory
nerve action potential (SNAP), and the spontaneous electrical activity
(SEA) were investigated. For the CMAP, the median and tibial nerves
were tested. The ulnar and peroneal nerves were tested when the
aforementioned nerves were not testable. The CMAP was classified as
abnormal when the amplitude reached or dropped below the absolute
lower limit of normal in the 2 nerves. For the SNAP, the same
definition of normality was set for the sural and median nerve. If it
was unable to test the median nerve, the radial nerve was used.
Spontaneous electrical activity was defined as presence of fibrillation
potentials and/or positive sharp waves in at least 2 muscles located in
at least 2 limbs. The muscles considered for this analysis were biceps
brachii (if impossible, deltoid muscle) and extensor digitorum commu-
nis (if impossible, interosseus digitorum muscle) for the upper limbs.
For the lower limbs, the gastrocnemius muscle (if impossible, tibialis
anterior) and the vastus lateralis (if impossible, vastusmedialis or rectus
femoris) were used.
2.4.2. Safety
The patients’ cardiorespiratory responses (heart rate, blood
pressure, oxygen saturation, and breathing frequency) are continu-
ously measured andwere recorded at the start and after 20minutes of
NMES. After stimulation, skin responses (redness, local edema, and
skin etching) were observed by the person who performed the NMES.
2.5. Statistical analysis
2.5.1. Feasibility
To assess potential differences between patients with a positive
response to NMES (contraction type 4 or 5; see First Online
Supplement) and those with a lesser or no response (contraction
type 1-3), the results were divided in “responders” and “nonre-
sponders.” Patients were qualified as responders if in at least 75% of
the NMES sessions, an effective contraction (type 4 or 5) was
detected. Otherwise, patients were classified as nonresponders. To
investigate how many successful sessions were performed per
patient, continuous analysis of the data was also performed. For
edema, a score of 0 (see Second Online Supplement) was classified as
no edema, a score of 1 to 4 was classified as edema. As for contraction,
also for edema, 75% or more of the sessions had to have a score of 0 to
be classified as having no edema.ical stimulation in critically ill patients, J Crit Care (2014), http://dx.doi.
Fig. 2. Flow chart.
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aminoglycosides, and NMBAs were dichotomous. To be noted as
administered, the medication should have been administered before
inclusion or during the study period. Analysis of administered dose
of medication showed similar results as the dichotomous results.
The only results shown are the latter results.
To investigate whether a contraction was obtained more success-
fully in the beginning of the patients’ ICU stay, a comparison between
session 1 and session 5 was performed. An effective response was
defined as a contraction type 4 or 5 (see First Online Supplement).
On the dichotomous data, a χ2 test was performed.
Continuous variables with normal distribution were reported as
mean and SD. Independent t tests were performed to evaluate the
differences between responders and nonresponders. For data not
normally distributed, median and interquartile range were reported,
and differences were examined using Mann-Whitney U test. Cate-
gorical variables are presented as numbers and percentage (%).χ2 test
was used to evaluate the differences between the responder and the
nonresponder group.
Multivariate analysis (backward stepwise) was performed to
identify which factors could contribute to the explanation in the
response to NMES. All variables in univariate analysis with P b .15
were considered as having a potential contribution in themultivariate
analysis. For all these variables, collinearity was explored. When 2
variables were significantly correlated, a bivariate regression analysis
was performed to identify significant contribution of the variables to
the model. If only 1 of the 2 variables had a significant contribution,
the nonsignificant variable was excluded in the multivariate analysis
due to collinearity. Furthermore, not more than 1 variable per 10
observations was included in the multivariate model. This selection
criterion has been used before by Sharshar et al [27].
2.5.2. Safety
Averages in heart rate, blood pressure, oxygen saturation, and
respiratory rate were calculated per patient before the start of the
NMES session and after 20 minutes of electrical stimulation. These
values were compared using a paired t test to detect changes before
and at the end of the NMES sessions.
The statistical significance of P value was set at .05. All statistical
analyses were performed using Statistical Package for the Social
Sciences (SPSS, version 19.0; SPSS Inc, Chicago, IL).
3. Results
3.1. Feasibility
Fifty patients were included in the feasibility study. The same 50
patients were used to investigate safety of NMES. The flow chart is
depicted in Fig. 2. On day 3, 23 patients were included, 14 patients
were included on day 4, and the remaining 13 were included on day 5.
The patients’ average ICU length of stay was 15 days. Because of one or
more of the temporary instabilities (fraction of inspired oxygen,
N60%; respiratory rate, N30/min; and temperature, N39°) and absence
of the patient due to other investigations or surgery, 346 sessions
(7 sessions per patient) were performed. Six of these sessions had to
be terminated prematurely due to inconvenience and agitation of the
patient after starting the NMES session.
Twenty-five patients (50%) were responders, whereas 25 patients
(50%) were nonresponders. This is depicted in Fig. 3. The differences
between responders and nonresponders are depicted in Table 1.
Patients with sepsis (P b .001), edema (P b .001), and those receiving
vasopressors (P = .011) were more frequently classified as nonre-
sponders. Furthermore, patients admitted to the medical ICU were
less likely to be responder compared with patients admitted to the
surgical intensive care unit (SICU) (P = .041).Please cite this article as: Segers J, et al, Feasibilityof neuromuscular electr
org/10.1016/j.jcrc.2014.06.024A statistically significant difference was found for the type of
contraction between session 1 and session 5 (P = .005) (n = 23). No
patient had a negative response (contraction type 1-3) in session 1
that changed to a positive response (contraction type 4-5) in session
5. In contrast, 22% of the patients changed from a positive response in
session 1 to a negative response in session 5.
In the univariate analysis, sepsis, edema, admission category,
medical intensive care unit (MICU) or SICU, corticosteroids, and
vasopressors had P b 0.15. Edema and sepsis were correlated, but both
contributed significantly to the bivariate model and were retained in
the multivariate analysis. Corticosteroids were eliminated due to
collinearity with edema, and MICU/SICU was eliminated due to
collinearity with admission category and sepsis. Consequently,
multivariate analysis was performed including sepsis, edema, vaso-
pressors, and admission category in the model. The backward
stepwise multivariate regression analysis withheld sepsis, edema,
and vasopressors in the equation. The explained variance (R2) was
59.5%. These results are shown in Table 2.
Thepossibility to elicit anadequate contraction couldnotbepredicted
by the NCS and EMG. The P values between type of contraction after the
NCS/EMG and CMAP (P= 1.000), SNAP (P= .367), and SEA (P= .422)
did not reach statistical significance.
When comparing the level of edema with the type of contraction per
session, a significantdifference (Pb .001)was foundas shown inTable3. An
inverse relationship can be found between the level of edema and the type
of contraction. Patients with no or almost no edema (level 1 and 2) were
more prone to have a good response to theNMES (type 4 or 5 contraction).
Patientswith considerable edema(level 3 and4)weremore likely tohave a
poor or no response to NMES (type 1-3 contraction). Furthermore, patients
with a level 4 edema never had a contraction type 3 or more.
3.2. Safety
The cardiovascular and respiratory responses are depicted in Table 4.
Noneof the investigated parameters changed significantly. Immediately
after the stimulation, a red skin under the electrodes was observed in
50%of the stimulation sessions. This redness gradually disappearedafter
the NMES session without detrimental responses of the skin.
4. Discussion
4.1. Feasibility
Neuromuscular electrical stimulation is a treatment modality
aiming to preserve muscle mass and strength. In this study, it wasical stimulation in critically ill patients, J Crit Care (2014), http://dx.doi.
Fig. 3. Pie chartwith50% responders (type4or 5 contraction in≥75of the sessions; right half of thepie chart, n=25 [50%])and50%nonresponders (left sideof thepie chart, n=25 [50%]).
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included patients. Edema, sepsis, and administration of vasopressors
negatively influenced the quality of the muscle contraction induced
by NMES.
The application of NMES in critically ill patients is attractive be-
cause specifically, in the early phase, selective type II atrophy and anTable 1
Baseline characteristics of responders and nonresponders
Main diagnosis Responders
(n = 25)
Nonresponders
(n = 25)
P
Sex, male, n (%) 15 (30) 11 (22) .258
Age, y (mean ± SD) 58 ± 13 62 ± 10 .166
Height, meter (mean ± SD) 1.70 ± 0.09 1.69 ± 0.11 .711
Weight, kg (mean ± SD) 73 ± 16 74 ± 16 .899
BMI, kg/m2 (mean ± SD) 25.1 ± 4.3 25.9 ± 5.5 .584
Admission category: .093
- Abdominal/pelvic surgery (n) 4 (16%) 3 (12%)
- Cardiac surgery (n) 2 (8%) 4 (16%)
- Gastrointestinal/hepatic disorder (n) 8 (32%) 2 (8%)
- Respiratory failure (n) 3 (12%) 5 (20%)
- Organ transplantation (n) 4 (16%) 3 (12%)
- Thoracic surgery (n) 0 (0%) 5 (20%)
- Hematology/oncology (n) 2 (8%) 0 (0%)
- Other diagnosis (n) 2 (8%) 3 (12%)
Sepsis, yes, n (%) 4 (8) 19 (38) b .001
Barthel index (/20) 18 ± 3 18 ± 2 .944
APACHE II score (0-70) 25 ± 8 27 ± 6 .578
GCS (0-15) 7 ± 3 9 ± 3 .216
S5Q (0-5) 2 ± 1 3 ± 2 .162
SAS (1-7) 2 ± 1 3 ± 1 .266
Intensity, mA 65 ± 8 69 ± 13 .236
No. of sessions/patient 5 ± 4 8 ± 7 .152
Medical ICU, n (%) 6 (12) 13 (26) .041
Edema, yes, n (%) 10 (20) 23 (46) b .001
Corticosteroids, yes, n (%) 12 (24) 18 (36) .114
Vasopressors, yes, n (%) 16 (32) 24 (48) .011
Inotropes, yes, n (%) 6 (12) 8 (16) .588
Aminoglycosides, yes, n (%) 9 (18) 6 (12) .355
NMBA, yes, n (%) 11 (22) 12 (24) .879
BMI indicates body mass index. APACHE II score, Acute Physiology And Chronic Health
Evaluation; S5Q, score on 5 questions; SAS, Sedation Agitation Scale; ICU, intensive care
unit; NMBA, neuromuscular blocking agents.
Results are expressed as mean ± SD for t test and Mann-Whitney U test. Numbers
are used for χ2. Barthel index is a score ranging from 0 to 20, APACHE II score from 0 to
70, GCS from 0 to 15, S5Q from 0 to 5, and SAS from 1 to 7.
Please cite this article as: Segers J, et al, Feasibilityof neuromuscular electr
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Interestingly, the recruitment order ofmuscle fibers duringNMESmay
specifically enhance contractions of the fast (type II) fibers [28] and
thus might theoretically counteract this process. In our study, 50% of
the patients were classified as responders. To our knowledge, only
Rodriguez et al [14] reported a success rate of 77% in patients with
sepsis. This is higher than our 50% success rate andmight be related to
the definition of “responders.” Rodriguez et al [14] reported a just
visible contraction as a good response to the stimulus. In our scoring,
this corresponds to a type 3 contraction and would “not” be sufficient
to be a responder. The choice for aminimal response type 4 contraction
in our study was set because of the expected dose-response
relationship of the stimulus. Snyder-Mackler et al [29] found that a
higher intensity of muscle contraction during NMES resulted in more
improvement inmuscle function. Therefore, it could be expected that a
type 4 or 5 contraction is more beneficial for the patient.
No differences were found in administration of NMBA and aminogly-
cosides between the responder and nonresponder group. Neuromuscular
blocking agents are known to block the neuromuscular transmission at
the neuromuscular junction by inhibition of acetylcholine. No stimulation
was provided to patients who had NMBA administration in the 24 hours
preceding the NMES session. Because no differenceswere found between
the 2 groups, there seems to be no negative long-term effects of NMBA on
muscle contractility. All patients treated with NMBA got the NMBA
administered in the first 48 hours on the ICU. Papazian et al [30] also did
notfindaneffect of earlyNMBAon the incidenceofmuscleweakness later
in the ICU.De Jongheetal [31] stated that theuseof aminoglycosidesalone
is not related with ICU-AW, but it is related with sepsis, which is a major
risk factor for ICU-AW. This is in accordance with our findings. Sepsis and
aminoglycosides were found to be collinear, and only sepsis contributed
significantly to the bivariate model. Statistically significant differencesTable 2
Stepwise backward multivariate analysis: variables in the model (see text for selection
method): sepsis, edema, vasopressors, and admission category
OR (95% CI) P
Sepsis 0.105 (0.020-0.536) .003
Edema 0.118 (0.017-0.804) .016
Vasopressors 0.076 (0.005-1.067) .028
OR indicates odds ratio; CI, confidence interval.
Probability for stepwise entry, 0.05 and removal, 0.10.
R2: 0.595.
ical stimulation in critically ill patients, J Crit Care (2014), http://dx.doi.
Table 3
Degree of edema and type of contraction per session for all patients (n = 50)
Contraction
type 1
Contraction
type 2
Contraction
type 3
Contraction
type 4
Contraction
type 5
Edema type 0 30 4 15 67 126
Edema type 1 21 13 30 88 44
Edema type 2 28 14 44 16 4
Edema type 3 18 7 8 3 0
Edema type 4 11 3 0 0 0
The explanation of contraction type and edema type can be found in Online Supplement 1
and 2.
Results are statistically significant (P b .001).
6 J. Segers et al. / Journal of Critical Care xxx (2014) xxx–xxxwere found for administration of vasopressors but not for inotropes.
Administration of vasopressors was also found to be independent of the
incidence of sepsis. The distinction between vasopressors and inotropes is
roughly made on the intended target. Vasopressor therapy is applied to
increase blood pressure, whereas inotropic therapy is applied to increase
cardiac output. Inotropes aremainly working on β1-adrenergic receptors,
which are especially located in the myocardium. Stimulation of β1
receptors causes an additional amount of influx of calcium into the
cytoplasm. Thus, this ensures an increase in contractility of the
myocardium leading to an increase in cardiac output. Vasopressors are
mainly working on α1-adrenergic receptors. These receptors are, among
others, richly present in the blood vessels of skeletal muscle and skin.
Stimulation of the α1 receptors also causes an additional amount of influx
of calcium. Thiswill elicit a vascular smoothmuscle contraction leading to
vasoconstriction and consequently to an increase in blood pressure.
However, vasoconstriction may severely restrict peripheral microcircu-
lation leading to hypoperfusion. Continuous application of vasopressors
decreases the rate of oxygen delivered by arteriolar vessels, increases
the rate of oxygen release to the microcirculation, and reduces tissue
PO2, including the muscle. This, in turn, may result in a hampering of a
muscle contraction. This is in accordance with our results because the
nonresponders had more vasopressors administered.
Sepsis was also a significant factor that was negatively associated
with muscle contractility. Rodriguez et al [14] also investigated the
effects of NMES in septic patients. They reported unsuccessful muscle
contractions in 23% of the NMES sessions. In addition, Poulsen et al
[13] concluded from a randomized controlled trial that NMES was
ineffective in septic patients. Several mechanisms may explain the
difficulties to obtain a sufficient muscle contraction in the presence of
sepsis. In general, it is known that sepsis leads to a hypercatabolic state
[32]. The proinflammatory state of sepsis causes activation of the
ubiquitin proteasome system and the lysosomal system [32]. As a result,
contractile protein synthesis will decrease, and protein degradationwill
increase in skeletal muscle. The total contractile protein content is
decreased by sepsis. Secondly, sepsis is also associated with mitochon-
drial dysfunction andadecreased adenosine triphosphate concentration
[33,34]. This might interfere with a muscle contraction as described
above. Thirdly, severe inflammation leads to higher levels of cytokines,
which affects the excitability of the muscle [35,36].
Limb edema had a significant negative influence on the generation
of a muscle contraction, with the inability to obtain a type 3, 4, or 5Table 4
Cardiovascular and respiratory responses during NMES for all patients (n = 50)
Pre NMES
session
After 20 min
of NMES
P
Heart rate (beats per minute) 89 ± 13 90 ± 14 .057
Systolic blood pressure (mm Hg) 130 ± 16 131 ± 15 .561
Diastolic blood pressure (mm Hg) 64 ± 8 65 ± 10 .342
O2 saturation (%) 97 ± 2 97 ± 3 .598
Respiratory rate (beats per minute) 20 ± 3 20 ± 4 .742
Results are expressed as mean ± SD.
Please cite this article as: Segers J, et al, Feasibilityof neuromuscular electr
org/10.1016/j.jcrc.2014.06.024contraction if a level 4 edema is present. Harper et al [37] observed
that, in ICU patients with limb edema, a higher intensity was needed
to obtain the same contraction. However, this high intensity is often
impossible to achieve due to the sensory discomfort [38]. In addition,
edema contributed to an increased distance between electrodes and
muscle [20], which in turn might reduce current density and impair
muscle contraction. Therefore, palpation was used in addition to the
visual inspection to minimize this type of bias.
Analysis showed that 22% of the patients with a good response
(type 4 or 5) in session 1 did not respond well (type 1-3) anymore in
session 5. This can be attributed to a change in parameters such as
development of edema or sepsis in the first days on the ICU. Because
this was not investigated in this study, this can only be assumed and
should be investigated in critically ill patients to make solid
conclusions on this result.
4.2. Safety
Neuromuscular blocking agents can be applied safely as none of the
cardiorespiratory parameters changed significantly. This was also found
byMeesen et al [15]. The change in heart rate in our patients did not reach
statistical significancebut showedaP=.057. Theactual change, however,
is onlyonebeatperminute.Asmall but significant change inheart ratehas
alsobeen foundbyGerovasili et al [22]. The raiseof 5beatsperminutewas
concluded to be a clinically irrelevant change. This is in accordance with
the change in results presented in this article.
The skin showed redness under the electrode in 50% of the cases
immediately after stimulation. This, however, disappeared gradually
after the NMES session and can be considered local hyperemia due to
the NMES. None of the patients reported negative consequences after
the NMES.
4.3. Limitations of the study
The cut-off to determinewhether a patient was a “responder”was set
as “a good contraction in 75% of the sessions.” This cut-offwas set because
aminimumof at least 4 stimulation sessions (the thirddayand the3more
days on the ICU) was considered as a potential minimal effective
stimulation. Although a dose-response relationship has been shown, no
data exist on a minimal contraction or minimal number of sessions
needed to prevent muscle atrophy in the critically ill patient. To be a
responder, at least 3 of these 4 sessions shouldbe performedwith a type4
or 5 contraction. If the patient had to stay in the ICU longer, the same 75%
limit was maintained. If patients with type 3 (or less) contraction do not
have an effect after NMES, however, should still be investigated.
The intensity on our stimulator was limited at 80 mA. It is possible
that an increase in maximal intensity above 80 mA resulted in fewer
nonresponders. However, literature on NMES in critically ill patients
reports intensity ranges below 80mA, namely, 19 to 55 mA [11], 40 to
80 mA [22], and below 54 mA [13]. Our mean intensities (65 mA for
the responder group and 69 mA for the nonresponder group) must be
considered high intensity.
With our device, we were limited to use 2 electrodes with the
standardized positioning of the electrodes as described in the
methods section. However, when no contraction was obtained, the
distal electrode was replaced to obtain a better muscle contraction.
However, this was never the case. The possibility remains, however,
that a higher rate of responders would have been obtained with more
electrodes on the different motor points of the quadriceps.
Because this is the first study to investigate the quality of the muscle
contraction, a self-made classification was developed to quantify the
contraction. The 4-point classification provides a clear distinction
between the different types of contraction to optimize the interrater
reliability. Three physiotherapists performed the stimulation
sessions; however, most observations (71%) were performed by one
researcher (JS).ical stimulation in critically ill patients, J Crit Care (2014), http://dx.doi.
7J. Segers et al. / Journal of Critical Care xxx (2014) xxx–xxx4.4. Clinical implications
This study identified patient characteristics (sepsis, edema, vasopres-
sors, and the admittance toMICU) thatmight impedewith the generation
of a sufficient muscle contraction by electrical muscle stimulation. It is
extremely important for future interventional studies to understand that
not every patient will respond similarly to stimulation.
Future studies should include stimulation of thedifferentmotor points
to optimize contraction. Furthermore, the stimulator should be able to
reach highermaximal intensities to increase the probability of obtaining a
contraction. In the analysis of the results, it should also be examined
whether being a responder or nonresponder affects results of NMES.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.jcrc.2014.06.024.References
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